Target intelligence / Profile preview

Dynamin pleckstrin homology domain (Dynamin PH domain)

Target
Dynamin PH domain
Molecular classification
Protein domain, Lipid-binding domain, GTPase-associated module
01

Overview

The Dynamin pleckstrin homology (PH) domain is a specialized protein module within the dynamin GTPase family, primarily responsible for targeting the enzyme to the plasma membrane by binding to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) (UniProt: Q05193). This interaction is essential for the recruitment of dynamin to the necks of budding vesicles, where it oligomerizes to facilitate membrane scission during clathrin-mediated endocytosis (PubMed: 10652310). Beyond its role in vesicle trafficking, the PH domain also interacts with the actin cytoskeleton and various signaling proteins, making it a central hub for cellular remodeling. In clinical contexts, mutations in the PH domain of Dynamin-2 are linked to neuromuscular disorders such as Charcot-Marie-Tooth disease and centronuclear myopathy (PubMed: 16227997). Furthermore, because dynamin is often hijacked by viruses for cellular entry and is overexpressed in several cancers, the PH domain has emerged as a viable therapeutic target. Small molecule inhibitors like MiTMAB and Dyngo-4a specifically target this domain to disrupt lipid binding, offering a strategy to block endocytosis-dependent processes in disease (PubMed: 21524197). However, the high conservation of PH domains across different proteins poses a challenge for achieving high drug specificity and minimizing off-target effects.

Other names
PH domain of dynaminDNM-PH domainPleckstrin homology domain of DNM1Pleckstrin homology domain of DNM2
02

Mechanism of action

Inhibition of the interaction between the pleckstrin homology domain and membrane phosphoinositides, specifically phosphatidylinositol 4,5-bisphosphate (PIP2), which prevents the recruitment of dynamin to the plasma membrane and inhibits vesicle scission.

03

Biological functions

Clathrin-mediated endocytosisVesicle scissionMembrane recruitmentIntracellular traffickingActin cytoskeleton organization
04

Disease associations

CancerCharcot-Marie-Tooth diseaseCentronuclear myopathyViral infectionEpilepsy
05

Safety considerations

Systemic toxicity from broad endocytosis inhibitionOff-target binding to other PH-domain containing proteinsPotential neurotoxicity
06

Interacting drugs

MiTMAB

4 more in the full profile.

07

Biomarkers

DNM2 mutation statusDynamin-2 expression levelsPI(4,5)P2 membrane concentration

Beyond the preview

Go deeper on Dynamin pleckstrin homology domain (Dynamin PH domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynamin pleckstrin homology domain (Dynamin PH domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call